Clinical Trial Update: Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

View source ↗

Summary

A completed clinical trial evaluating the use of 68Ga-DOTATATE PET imaging in neuroendocrine carcinoma of the gastrointestinal tract.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Carcinoma

Drugs mentioned

• 68Ga-DOTATATE (Gallium-68 DOTATATE)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Neuroendocrine Carcinoma | Status: COMPLETED